U.S., July 14 -- ClinicalTrials.gov registry received information related to the study (NCT07698756) titled 'A Clinical Study of HRS-8797 in Healthy Participants' on July 07.
Brief Summary: The purpose of this phase I study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-8797 in healthy participants.
Study Start Date: July, 2026
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis
Intervention:
DRUG: HRS-8797
Specified dose on specified days
DRUG: Placebo
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Chengdu Suncadia Medicine Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....